1-4 of 4
Sara M. Tolaney
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Navigating the HER2-Low Paradigm in Breast Oncology: New Standards, Future Horizons

Paolo Tarantino, Giuseppe Curigliano, Sara M. Tolaney
Journal: Cancer Discovery
Cancer Discov (2022) 12 (9): 2026–2030.
https://doi.org/10.1158/2159-8290.CD-22-0703
Published: 02 September 2022
View article titled, Navigating the HER2-Low Paradigm in Breast Oncology: New Standards, Future Horizons
Open the PDF for Navigating the HER2-Low Paradigm in Breast Oncology: New Standards, Future Horizons in another window
Journal Articles

Inhibition of CDK4/6 Promotes CD8 T-cell Memory Formation

Max Heckler, Lestat R. Ali, Eleanor Clancy-Thompson, Li Qiang, Katherine S. Ventre, Patrick Lenehan, Kevin Roehle, Adrienne Luoma, Kelly Boelaars, Vera Peters, Julia McCreary, Tamara Boschert, Eric S. Wang, Shengbao Suo, Francesco Marangoni, Thorsten R. Mempel, Henry W. Long, Kai W. Wucherpfennig, Michael Dougan, Nathanael S. Gray, Guo-Cheng Yuan, Shom Goel, Sara M. Tolaney, Stephanie K. Dougan
Journal: Cancer Discovery
Series: Author Choice
Cancer Discov (2021) 11 (10): 2564–2581.
https://doi.org/10.1158/2159-8290.CD-20-1540
Published: 01 October 2021
View article titled, Inhibition of CDK4/6 Promotes CD8 T-cell Memory Formation
Open the PDF for Inhibition of CDK4/6 Promotes CD8 T-cell Memory Formation in another window
Includes: Supplementary data
Journal Articles

The Genomic Landscape of Intrinsic and Acquired Resistance to Cyclin-Dependent Kinase 4/6 Inhibitors in Patients with Hormone Receptor–Positive Metastatic Breast Cancer

Seth A. Wander, Ofir Cohen, Xueqian Gong, Gabriela N. Johnson, Jorge E. Buendia-Buendia, Maxwell R. Lloyd, Dewey Kim, Flora Luo, Pingping Mao, Karla Helvie, Kailey J. Kowalski, Utthara Nayar, Adrienne G. Waks, Stephen H. Parsons, Ricardo Martinez, Lacey M. Litchfield, Xiang S. Ye, Chunping Yu, Valerie M. Jansen, John R. Stille, Patricia S. Smith, Gerard J. Oakley, Quincy S. Chu, Gerald Batist, Melissa E. Hughes, Jill D. Kremer, Levi A. Garraway, Eric P. Winer, Sara M. Tolaney, Nancy U. Lin, Sean G. Buchanan, Nikhil Wagle
Journal: Cancer Discovery
Cancer Discov (2020) 10 (8): 1174–1193.
https://doi.org/10.1158/2159-8290.CD-19-1390
Published: 03 August 2020
View article titled, The Genomic Landscape of Intrinsic and Acquired Resistance to Cyclin-Dependent Kinase 4/6 Inhibitors in Patients with Hormone Receptor–Positive Metastatic Breast Cancer
Open the PDF for The Genomic Landscape of Intrinsic and Acquired Resistance to Cyclin-Dependent Kinase 4/6 Inhibitors in Patients with Hormone Receptor–Positive Metastatic Breast Cancer in another window
Includes: Supplementary data
Journal Articles

Efficacy and Safety of Abemaciclib, an Inhibitor of CDK4 and CDK6, for Patients with Breast Cancer, Non–Small Cell Lung Cancer, and Other Solid Tumors

Amita Patnaik, Lee S. Rosen, Sara M. Tolaney, Anthony W. Tolcher, Jonathan W. Goldman, Leena Gandhi, Kyriakos P. Papadopoulos, Muralidhar Beeram, Drew W. Rasco, John F. Hilton, Aejaz Nasir, Richard P. Beckmann, Andrew E. Schade, Angie D. Fulford, Tuan S. Nguyen, Ricardo Martinez, Palaniappan Kulanthaivel, Lily Q. Li, Martin Frenzel, Damien M. Cronier, Edward M. Chan, Keith T. Flaherty, Patrick Y. Wen, Geoffrey I. Shapiro
Journal: Cancer Discovery
Series: Author Choice
Cancer Discov (2016) 6 (7): 740–753.
https://doi.org/10.1158/2159-8290.CD-16-0095
Published: 30 June 2016
View article titled, Efficacy and Safety of Abemaciclib, an Inhibitor of CDK4 and CDK6, for Patients with Breast Cancer, Non–Small Cell Lung Cancer, and Other Solid Tumors
Open the PDF for Efficacy and Safety of Abemaciclib, an Inhibitor of CDK4 and CDK6, for Patients with Breast Cancer, Non–Small Cell Lung Cancer, and Other Solid Tumors in another window
Includes: Supplementary data